muPharma

medical devices

About

muPharma is a business based in Victoria, Australia that has developed various novel, ultrasound based, non-invasive devices to deliver drugs and vaccines to the body that would ordinarily require injections or other highly invasive delivery means. Principal sites of application include the eye (anterior and posterior segment) and the inside of the mouth. Ocular opportunities include: 1) Non-invasive delivery of biologics (including nucleic acid based personalised drugs and monoclonal antibody drugs) to the retina (via the uveal tract) particularly for the treatment of (dry and wet) AMD, DME and genetically inherited diseases; 2) Non-invasive delivery of Riboflavin to the cornea; and 3) Non-invasive delivery of any chemically synthesised drug to anterior / posterior segments. Immunology opportunities include the creation of protective, long lasting mucosal immunity and systemic against diseases that enter the body via mucous membranes including COVID-19, Influenza, Norovirus, Chlamydia, HIV, Tuberculosis as well as a host of other communicable pathogens.

Technologies

Google Cloud Hosting Wix Mobile Friendly Varnish Android Remote Canva

Keywords

corneal drug delivery medical equipment and supplies manufacturing patented ultrasound technology mucosal vaccine for influenza non-invasive drug delivery disposable tips medical devices needle-free vaccine non-invasive ocular treatment vaccine delivery system systemic immunity patent protected medical device vaccine delivery immunology microscopic features biologics delivery covid-19 mucosal protection biotechnology pharmaceuticals keratoconus collagen cross-linking macular degeneration treatment australian university collaboration ultrasound technology ophthalmology ophthalmology devices hiv mucosal immunity ultrasound tissue permeability biomedical engineering services biocompatible materials

Location

Melbourne, Victoria, Australia, 3142

Related Companies

Companies in the same industry